000 03184nam a22004215c 4500
999 _c5971
_d5971
001 5971
003 ES-MaUEC
005 20200615155514.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180929s2019 gw a s |||| 0|eng d
020 _a9783319969893
024 7 _a10.1007/978-3-319-96989-3
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280.K5
_b.R34 2019EB
245 0 0 _aRare Kidney Tumors.
_bComprehensive Multidisciplinary Management and Emerging Therapies
_cedited by Gabriel G. Malouf, Nizar M. Tannir.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2019.
300 _aIX, 128 páginas 9 ilustraciones, 8 ilustraciones a color
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 0 _aMedicine (Springer-11650)
505 0 _aIntroduction -- Hereditary RCC Syndromes -- Wilms Tumor -- Renal Cell Carcinomas in Children -- Chromophobe Renal Cell Carcinomas -- Papillary Renal Cell Carcinoma -- Renal Medullary Carcinomas -- Collecting Duct Carcinomas -- Translocation Renal Cell Carcinomas -- Angiomylipoma -- Sarcomatoid and Rhabdoid Renal Cell Carcinoma -- Conclusion.
520 3 _aThis book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist. Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors. .
653 0 _aOncology  .
653 0 _aUrology.
653 0 _aPediatrics.
700 1 _aMalouf, Gabriel G.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aTannir, Nizar M.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_990238
710 2 _aSpringerLink (Online service)
_9106937
776 0 8 _iPrinted edition:
_z9783319969886
776 0 8 _iPrinted edition:
_z9783319969909
776 0 8 _iPrinted edition:
_z9783030072810
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-96989-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db